✨ Your Portfolio is fetched and updated from zerodha.
Market Cap
₹444 Cr.
P/E
28.92
About
Zim Laboratories Ltd has established itself as one of the preferred healthcare solution providers in the field of New Drug Delivery Systems (NDDS). The company has pioneered several innovative techn… Read more
Zim Laboratories Ltd has established itself as one of the preferred healthcare solution provi… Read more
Low
80
52W Range
High
128
  • Zim Laboratories
  • Venus Remedies
  • Lyka Labs
  • TJI Pharma - Small Cap

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

8 Yes

Positive for this company

1 Neutral

Neutral for this company

8 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Customer Segment

Capex

Asset Break-Up

Operational Metrics

    Select a Metric
    • R&D as a % of Total Sales (%)
    Peer Comparison
    Corporate Actions
    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less
    Customers
    • Gufic Biosciences Ltd.
    • RPG Life Sciences Ltd.
    • Sun Pharmaceutical Industries Ltd.
    • Alkem Laboratories Ltd.
    • Mankind Pharma
    FAQs on Zim Laboratories Ltd. Business

    Zim Laboratories Ltd is a leading healthcare solution provider specializing in New Drug Delivery Systems. They have developed innovative technologies and products in areas such as Pellets, Multiplets, Resinates, Herbals, and Diagnostics.

    Zim Laboratories major competitors are Venus Remedies, Lyka Labs, Medico Remedies, Jenburkt Pharma, Brooks Laboratories, Albert David, Ind-Swift Lab..
    Market Cap of Zim Laboratories is ₹445 Crs.
    While the median market cap of its peers are ₹476 Crs.

    Zim Laboratories seems to be less financially stable compared to its competitors.
    Altman Z score of Zim Laboratories is 3.03 and is ranked 8 out of its 8 competitors.

    Company Filing
    2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release Mar Jun Sep Dec Mar Jun Dec Mar Jun Sep Dec Jun Sep Dec
    Investor Presentation Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Dec Dec Feb Jun Sep Dec
    Conference Call Mar Sep Mar Jun Sep Dec
    Conference Call SummaryCon Call Summary
    Discussions & Analysis
    Ideas Dashboard
    Timeline
    Watchlist
    Portfolio
    Alerts
    Research
    Stock Screener
    Market
    Raw Material